Ligand Pharmaceuticals
LGND
$85.29
Share price
1.45%
Change (1 day)
9.92%
Change (1 year)
Market capitalization of Ligand Pharmaceuticals (LGND)
Market cap: $1.53 Billion
As of May 2024 Ligand Pharmaceuticals has a market cap of $1.53 Billion. This makes Ligand Pharmaceuticals the world's 4585th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Ligand Pharmaceuticals from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.53 B | 23.03% |
| 2023 | $1.24 B | 10.35% |
| 2022 | $1.12 B | -56.28% |
| 2021 | $2.58 B | 61.4% |
| 2020 | $1.59 B | -8.85% |
| 2019 | $1.75 B | -37.74% |
| 2018 | $2.81 B | -2.49% |
| 2017 | $2.88 B | 36.08% |
| 2016 | $2.12 B | -1.81% |
| 2015 | $2.16 B | 107.65% |
| 2014 | $1.04 B | -3.26% |
| 2013 | $1.07 B | 143.96% |
| 2012 | $0.44 B | 88.98% |
| 2011 | $0.23 B | 34.2% |
| 2010 | $0.17 B | -31.26% |
| 2009 | $0.25 B | -2.69% |
| 2008 | $0.26 B | -42.87% |
| 2007 | $0.45 B | -58.2% |
| 2006 | $1.08 B | 33.71% |
| 2005 | $0.81 B | -4.09% |
| 2004 | $0.84 B | -21% |
| 2003 | $1.07 B | 180.23% |
| 2002 | $0.38 B | -64.33% |
| 2001 | $1.07 B |
End of Day market cap according to different sources
On May 14th, 2024 the market cap of Ligand Pharmaceuticals was reported to be:
$1.53 Billion
$1.53 Billion
$1.53 Billion
$1.53 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $364.32 B | 23,678.97% | 🇺🇸 USA |
 Pfizer PFE | $161.15 B | 10,418.59% | 🇺🇸 USA |
 Eli Lilly LLY | $726.09 B | 47,291.10% | 🇺🇸 USA |
 Amgen AMGN | $167.05 B | 10,803.24% | 🇺🇸 USA |
 Baxter BAX | $18.05 B | 1,078.39% | 🇺🇸 USA |
 Merck MRK | $327.46 B | 21,273.38% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $91.34 B | 5,861.74% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $93.41 B | 5,997.32% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | $0.21 B | -86.20% | 🇺🇸 USA |